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Abstract
The present study includes cloning and expression of recombinant Leishmania donovani histone proteins (rLdH2B, rLdH3,
rLdH2A and rLdH4), assessment of their immunogenicity in Leishmania infected cured patients/endemic contacts as well as
in cured hamsters and finally evaluation of their prophylactic efficacy in hamsters against L. donovani challenge. All
recombinant proteins were expressed and purified from the heterologous bacterial host system. Leishmania infected cured
patients/endemic contacts as well as cured hamsters exhibited significantly higher proliferative responses to individual
recombinant histones and their pooled combination (rLdH2B+rLdH3+rLdH2A+rLdH4) than those of L.donovani infected
hosts. The L.donovani soluble antigens (SLD) stimulated PBMCs of cured/exposed and Leishmania patients to produce a
mixed Thl/Th2-type cytokine profile, whereas rLdH2B, rLdH3, rLdH2A, rLdH4 and pooled combination (rLdH2-4) stimulated
the production of Th1 cytokines IFN-c, IL-12 and TNF-a but not Th2 cytokines IL-4 or IL-10. The immunogenicity of these
histone proteins along with their combination was also checked in cured hamsters where they stimulated higher
lymphoproliferation and Nitric oxide production in lymphocytes of cured hamsters than that of infected controls. Moreover,
significantly increased IgG2 response, an indicative of cell mediated immunity, was observed in cured hamsters against
these individual proteins and their combination as compared to infected hamsters. Further, it was demonstrated that
rLdH2B, rLdH3, rLdH2A and rLdH4 and pooled combination were able to provide considerable protection for hamsters
against L. donovani challenge. The efficacy was supported by the increased inducible Nitric Oxide Synthase (iNOS) mRNA
transcripts and Th1-type cytokines - IFN-c, IL-12 and TNF-a and down-regulation of IL-4, IL-10 and TGF-b. Hence, it is inferred
that pooled rLdH2-4 elicits Thl-type of immune responses exclusively and confer considerable protection against
experimental Visceral Leishmaniasis.
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Introduction
Visceral leishmaniasis (VL) is one of the most severe forms of
Leishmanases caused by an intracellular protozoan parasite of the
Leishmania donovani/L. infantum/L. chagasi complex and transmitted
through the bites of the sand fly Phlebotomus argentipes. The disease is
known to cause progressive fatal disease in poor people
particularly belonging to North-eastern part of Indian sub-
continent. An average of more than 90% of VL cases in India is
reported from Bihar alone [1,2]. Recent epidemics of VL in Sudan
and India have resulted in over 100,000 deaths [3]. VL is
characterized by prolonged fever, hepatosplenomegaly, anaemia,
weightloss, cachexia, pancytopenia, hypergammaglobulinemia
and suppressed cellular immune response [4]. Due to the non-
availability of an ideal antileishmanial drug 350 million people are
globally at the risk of acquiring infection with Leishmania parasites
worldwide [5]. The disease is also emerging as an important
opportunistic infection in immunocompromised patients, especial-
ly those co-infected with HIV [6,7,8].
The situation has further worsened with the emergence of drug
resistance in various regions of endemicity and improper
chemotherapeutic treatment of visceral leishmaniasis [6]. Current
VL therapy is based on the long-term parenteral administration of
pentavalent antimonials, which, despite being expensive and
highly toxic, has been the standard treatment for over 50years.
Currently available drugs are not safe for long term continual use
for being highly cost ineffective. Due to the lack of effective and
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low-cost treatments, it is imperative to develop an ideal vaccine
which would be protective against VL. So far killed or live-
attenuated parasites, as well as a large number of Leishmania
antigens from different species either in DNA or protein form have
been tested as vaccines against VL with little success.
In current scenario, there has been significant progress in
understanding the immuno-pathogenesis of leishmaniasis. The
parasite antigen able to induce an immune response has been
predominantly associated with the identification of proteins that
may be used for vaccine development. Most of the studies aimed at
identifying antigens from Leishmania spp have searched for
molecules with the ability to stimulate Th1-type responses, which
are known to be the major defense mechanism against Leishmania
infection [9,10,11,12,13,14,15,16].
Histone proteins- H2A, H2B, H3 & H4 which play an
important role in DNA packaging, transcription and gene
regulation, have been reported previously as potent vaccine
candidate against cutaneous and viscerocutaneous leishmaniasis
[17,18,19], but their protective role against VL is still to decipher.
It was also revealed from previous studies carried out in cutaneous
and visceral leishmaniasis patients, that the humoral response
induced was found to be specific for Leishmania histones since no
cross reactivity of VCL sera with mammalian histones were
observed [20]. In the present study cloning, expression, purifica-
tion and molecular characterization of these four histone proteins
of L. donovani was reported for the first time. The ability of
recombinant rLdH2B, rLdH3, rLdH2A and rLdH4, either
individually or in the pooled form (rLdH2-4) was also assessed
to stimulate the immune responses in PBMCs/lymphocytes of
leishmania infected cured/endemic contact individuals as well as
hamsters. In addition to it the protective efficacy of individual
histones and their combinations was measured in naive hamsters
against L. donovani challenge.
Materials and Methods
Ethical statement
All animal care and experimental use conformed to Committee
for the Purpose of Control and Supervision on Experiments on
Animals guidelines for laboratory animal facilities and were
approved by the Committee on the Ethics of Animal Experiments
of Central Drug Research Institute (protocol number IAEC/
2009/Para/117). The protocol and study with patients’ was
approved by the Ethics committee of the Kala-azar Medical
Research Centre, Muzaffarpur (Protocol # EC-KAMRC/Vac-
cine/VL/2007-01) and written informed consent was obtained
from patients before enrollment in this study. All the human
subjects underwent clinical examination by a local physician for
leishmanial and other possible infections.
Animal
Laboratory-bred male golden hamsters (Mesocricetus auratus,
45–50 g) from the Institute’s animal house facility were used as
experimental host. They were housed in climatically controlled
room and fed with standard rodent food pellet (Lipton India Ltd.,
Bombay) and water ad libitum. The experimental animals were
monitored daily till the termination of the study and were
autopsied at that time point or whenever required under the deep
anesthesia with over dosages of sodium thiopentone in order to
reduce the suffering level in experimental animals. Thiopentone
was injected into animals with saline solution at a dose of 50 mg/
kg of the body weight through intraperitoneally route.
Parasites Culture
The L. donovani WHO reference strain Dd8 (MHOM/In/80/
Dd8) has been cultured in vitro as described elsewhere (21). For
bulk amount, promastigotes were cultured in RPMI-1640 medium
supplemented with 10% heat-inactivated fetal bovine serum
(Sigma, USA), 100 U/ml penicillin (Sigma, USA) and 100 mg/
ml streptomycin (Sigma, USA) at 26uC61uC for 3–5 days 75 cm2
culture flasks (Corning). The strain has also been maintained in
vitro as well as in vivo in hamsters through serial passages, i.e. from
amastigote to amastigote [21].
Table 1. Sequences of forward and reverse primers of Histone gene.
S.No Gene Forward Primer Reverse Primer
1 H2B 59GGATCCATGTCGCGCACCAAGGAGACC-39 59GAATTCGTCCCCCTCACCGCGCAG-39
2 H3 59GGATCCATGGCCTCTTCTCACTCTGCTTC-39 59GAATTCACGCGACGGGCACGACACGGC-39
3 H2A 59-GAATTCACGCGACGGGCACGACACGGC-39 59GAATTCTGCGCTCGG TGTCGCCTTGCC-39
4 H4 59-GGATCCATGGCTACTCCTCGCAGCGC-39 59-GAATTCCGCGTAGCCGTACAGGATGTG-39
doi:10.1371/journal.pone.0097911.t001
Table 2. Sequences of forward and reverse primers of
hamster cytokines used for quantitative real time RT-PCR.
S.N. Primer Primer sequence
1. HGPRT Forward 59 GATAGATCCACTCCCATAACTG 39
Reverse 59 TACCTTCAACAATCAAGACATTC 39
2. TNF-a Forward 59 TTCTCCTTCCTGCTTGTG39
Reverse 59 CTGAGTGTGAGTGTCTGG39
3. IFN-c Forward 59 GCTTAGATGTCGTGAATGG 39
Reverse 59 GCTGCTGTTGAAGAAGTTAG 39
4. IL-12 Forward 59 TATGTTGTAGAGGTGGACTG39
Reverse 59 TTGTGGCAGGTGTATTGG 39
5. TGF-b Forward 59 ACGGAGAAGAACTGCTGTG 39
Reverse 59 GGTTGTGTTGGTTGTAGAGG 39
6. IL-4 Forward 59 GCCATCCTGCTCTGCCTTC 39
Reverse 59 TCCGTGGAGTTCTTCCTTGC 39
7. IL-10 Forward 59 TGCCAAACCTTATCAGAAATG39
Reverse 59 AGTTATCCTTCACCTGTTCC 39
8. iNOS Forward 59 CGACGGCACCATCAGAGG 39
Reverse 59AGGATCAGAGGCAGCACATC 39
doi:10.1371/journal.pone.0097911.t002
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Cell line
Mouse macrophage cell line J774A.1 was procured from Tissue
culture Facility of the institute and maintained in RPMI-1640
through serial passage in 75 cm2 culture flasks (Corning) at 37uC
and 5% CO2. The confluent cells were harvested using cell
scrapper for the estimation of nitric oxide (NO) production.
Preparation of soluble L. donovani promastigote antigen
(SLD)
SLD was prepared as per method described by [22]. Briefly,
stationary phase promastigotes (109) were harvested from 3 to 4
days of culture and washed four times in cold PBS, resuspended in
PBS containing protease inhibitor cocktail (Sigma, USA) and
subjected to ultrasonication and higher range of centrifugation at
40,0006g for 30 min. The protein content of the supernatant was
estimated and stored at 270uC for the use of longer time.
Cloning, expression and purification of L. donovani
histone proteins (LdH2B, LdH3, LdH2A, LdH4)
Genomic DNA was isolated from 108 L. donovani promastigotes,
washed and suspended in NET buffer (10 mM Tris-HCl (pH 7.5),
100 mM NaCl, and 1 mM EDTA) and incubated with proteinase
K (1 mg/ml; Invitrogen Life Technologies) and 0.5% SDS at
50uC for 3 h. Nucleic acids were extracted by phenol: chloroform:
isoamyl alcohol extraction and ethanol precipitation. Genomic
DNA was spooled and subjected to RNase (100 mg/ml) treatment.
LdH2B, LdH3, LdH2A and LdH4 gene were amplified using
Ldhistone-specific primers which were designed as mentioned in
Table1 on the basis of L.infantum histone - LdH2B, LdH3, LdH2A,
LdH4 genes sequences available at National Center for Biotech-
nology Information (NCBI). PCR was performed using Taq
Polymerase (Fermentas) lacking a 39–59 exonuclease activity in a
Thermocycler (Bio-Rad) under conditions at one cycle of 95uC for
3 min, 30 cycles of 95uC for 1 min, 55uC for 1 min, and 72uC for
2 min, and finally one incubation at 72uC for 10 min. Amplified
PCR product was electrophoresed in agarose gel and eluted by
using Gen Elute Columns (Qiagen). Eluted product was ligated in
pTZ57R/T (T/A) cloning vector (Fermentas) and transformed
into competent Escherichia coli DH5a cells. The transformants were
screened for the presence of recombinant plasmids with the
rLdH2B, rLdH3, rLdH2A, rLdH4 genes insert by gene-specific
PCR under similar conditions as previously mentioned. Isolated
positive clones were sequenced (from South Campus, Delhi
University, NewDelhi, India) and later submitted to the NCBI.
(http://www.ncbi.nlm.nih.gov/nuccore/GU066394/HM057222/
JF78400/GQ845113).
(Accession nos. GU066394/HM057222/JF78400/GQ845113).
rLdH2B, rLdH3, rLdH2A, rLdH4 were further subcloned at the
BamHI and EcoRI site in bacterial expression vector- pET28a+
(Novagen).Their expressions were checked in bacterial cells by
Figure 1. (a,b,c & d)- PCR of of LdH2B, LdH3, LdH4 and LdH2A genes. (e, f, g, & h)- Expression and purification of LdH2B, LdH3, LdH2A, LdH4
from E. coli rossetta cells, WCL of transformed E. coli separated on 12% acrylamide gel and stained with Coomassie blue, M: Molecular wt. markers;
Lane 1: Flow through; lane 2&3: Washing fraction; Lane 4 & 5: eluted protein. (i, j, k & l)-Western blot analysis using anti-rLhistone antibody in
uninduced WCL, induced WCL and leishmania WCL - M: Mol wt marker, Lane 1: uninduced WCL, Lane 2: induced WCL, Lane 3: Purified protein, Lane 4:
whole cell lysate of Leishmania.
doi:10.1371/journal.pone.0097911.g001
LdHistones Are Immunogenic & Protective against VL
PLOS ONE | www.plosone.org 3 June 2014 | Volume 9 | Issue 6 | e97911
transforming the rLdH2B+ pET28a+/rLdH3+ pET28a+/
rLdH2A+ pET28a+/rLdH4 + pET28a+ constructs in E. coli
Rosetta strain separately. The transformed cells were inoculated in
to 5 ml Luria Bertani medium (LB) containing 34 mg/mL of
chloramphenicol and 35 mg/mL kanamycin and allowed to grow
at 37uC with shaking at 200 rpm. Cultures in logarithmic phase (at
OD 600 of ,0.5–0.6) were induced for 16 h with 1.0 mM
isopropyl-b-D-thiogalactopyranoside (IPTG) at 20uC. After in-
duction, 1 ml cells were lysed in 100 ml sample buffer (50 m M
Tris-HCl (pH 8), 10% SDS, and 0.05% bromophenol blue, with
100 mM DTT) and whole cell lysates (WCL) were analyzed by
12% SDS-PAGE. Uninduced control cultures were analyzed in
parallel. The overexpression of rLdH2B, rLdH3, rLdH2A and
rLdH4 was visualized by staining the gel with Coomassie brilliant
blue R-250 (Sigma).
For purification of each histone protein, 200 mL of LB medium
induced as mentioned above and processed by affinity chroma-
tography using Ni2+chelating resin to bind the His6-tag fusion
peptide derived from the pET28a+ vector. The cell pellets were
resuspended separately in 4 mL of lysis buffer (50 mM Tris-HCL
(pH 8.0), 300 mM NaCl) containing 1:200 dilution of protease
cocktail inhibitor (Sigma) and 1% Triton X-100, incubated for
30 min on ice with 1 mg/mL lysozyme (Sigma), and the
suspension was sonicated for 10620 sec (with 30 s intervals
between each pulse) on ice. The sonicated cells were centrifuged at
15,000 g for 30 min at 4uC, and the supernatant was incubated at
4uC for 1 h with the 2 mL of Ni–NTA Superflow resin (Qiagen,
Hilden, Germany) previously equilibrated with lysis buffer. After
washing with buffer (50 mM Tris-HCL (pH 8.0), 300 mM NaCl),
containing different concentrations of imidazole i.e. 20,50 and
100 mM, each of the purified recombinant protein was eluted with
elution buffer (50 mM Tris-HCL, 300 mM NaCl, and 250 mM
imidazole, pH 7.5). The eluted fractions were analyzed by 12%
SDS–PAGE followed by Coomassie blue staining. The protein
content of the fractions was estimated by the Bradford method
using BSA as standard.
Production of polyclonal antibodies against rLdH2B,
rLdH3, rLdH2A, rLdH4 and Western blot analysis
The purified rLdH2B, rLdH3, rLdH2A and rLdH4 proteins
were used for raising antibodies in Swiss mice. Mice were first
immunized using 50 mg of each of the recombinant histone
proteins in Freund’s complete adjuvant. After 15 days, the mice
were given 3 booster doses of 25 mg of the protein in incomplete
Freund’s adjuvant at 2-weeks interval and blood was collected for
serum 8 days after the last immunization. Antibody titre was
determined by ELISA and was found to be 1:64000. For
immunoblotting experiment, purified r-histone protein along with
SLD were resolved in 12% SDS–PAGE and transferred to
nitrocellulose membrane using a semi-dry blot apparatus (Amer-
sham) [23]. After overnight blocking in 5% BSA, the membrane
was incubated with antiserum to the r-histone protein at a dilution
of 1:2000 for 120 min at room temperature (RT). The membrane
was washed three times with PBS containing 0.5% Tween 20
(PBS-T) and then incubated with secondary antibody - goat anti-
mice IgG HRP conjugate (Bangalore Genie) at a dilution of
1:10,000 for 1 h at RT. The blot was developed by using
diaminobenzidine hydrochloride + imidazole +H2O2 (Sigma).
Patients and isolation of PBMCs
The study groups of human samples were as follows:
[1] Six treated cured patients (3 males and 3females, age
ranging from 15–50 years) from hyper-endemic areas of Bihar. All
the patients had received a complete course of amphotericin B and
Figure 2. Cellular responses of rLdH2B, rLdH3, rLdH2A, rLdH4,
and pooled(H2-4) of L.donovani in hamsters. (a) XTT response of
mononuclear cells (lymph nodes) from normal, L.donovani infected (30
day p.c.) and treated hamsters in response to Con A, SLD and rLdH2B,
rLdH3, rLdH2A, rLdH4 and pooled (rLdH2-4) at 10 mg/ml each.
Proliferation was represented as mean OD of stimulated culture-mean
OD of unstimulated control. Each bar represents the pooled data (mean
6 S.D. value) of 6 hamsters and the data represent the means of
triplicate wells 6 the S.D. (b) Nitric oxide production (mM) by the J774
A.1 cells were primed with the supernatants of stimulated lymphocytes
(3 days with mitogen and 5 days with antigens) of normal, infected and
cured hamsters in response to rLdH2B, rLdH3, rLdH2A, rLdH4 and
pooled (H2-4), SLD and LPS respectively at 10 mg/ml each. The
estimation of NO production was done using Greiss reagent in
supernatants collected from macrophage cultures 24 h after incubation
and the absorbance of the reaction product was measured at 540 nm.
Significance values indicate the difference between the SLD and
rLdH2B, rLdH3, rLdH2A, rLdH4, and pooled (H2-4) stimulation (**, p,
0.01; ***, p,0.001).
doi:10.1371/journal.pone.0097911.g002
Figure 3. Cellular responses of rLdH2B, rLdH3, rLdH2A, rLdH4,
and pooled (rLdH2-4) of L.donovani in patients sample.: XTT
response of PBMC from normal, L. donovani infected, Endemic and
cured patients in response to PHA, SLD and rLdH2B, rLdH3, rLdH2A,
rLdH4 and pooled (H2-4) at 10 mg/ml each. Proliferation was
represented as mean OD of stimulated culture - mean OD of
unstimulated control. Each bar represents the data (mean 6 S.D. value)
of triplicate wells 6 the S.D. pooled (rLdH2-4) shown significantly
higher cellular response. Significance values indicate the difference
between the SLD and rLdH2B, rLdH3, rLdH2A, rLdH4, and pooled
(rLdH2-4) stimulation (**, p,0.01; ***, p,0.001).
doi:10.1371/journal.pone.0097911.g003
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had recovered from VL. Samples were collected for 2 months to 1
year after the completion of treatment. The diagnosis was
established in all cases by demonstration of parasites in splenic
aspirates and found negative at the time of study.
[2] Six endemic household contacts (2 males and 4 females, age
range-25 to 45 years) that have neither showed clinical symptoms
nor received any treatment for Kala-azar. They belonged to the
family of infected/cured patients.
[3] Six infected patients (3 males and 3 females, age range- 10 to
55 years) showing clinical symptoms of Kala-azar.
[4] Six normal healthy donors (2 males and 4 females, age range
10–50 years) from non-endemic areas, without any history of
leishmaniasis, served as negative control.
Heparinized venous blood (10 ml each) was collected from all
the study subjects and peripheral blood mononuclear cells
(PBMCs) were isolated from blood by Ficoll-Hypaque density
gradient centrifugation (Histopaque 1077, Sigma, USA) as
described by [21]. A final suspension of 16106 cells/ml was made
in complete RPMI medium (cRPMI) after determining cell
viability by trypan blue staining method. These were used for
various immunological assays.
Treatment of L. donovani infected hamsters and isolation
of mononuclear cells (lymph node cells)
Approximately 20 hamsters, infected with 107 amastigotes
intracardially, were assessed one month later for parasitic burden
by splenic biopsy through a small incision in the upper left quarter
of the abdomen and a small piece of splenic tissue was cut and dab
smears were made on slides. The incised portion was stitched with
nylon suturing thread. Following biopsy, an adequate amount of
antibiotic powder (Neosporin) was applied to the stitched portion
and finally sealed with tincture of benzoin. In addition, neosporin
sulphate (100 mg/kg of body weight) was also given orally the day
before and the day after the biopsy for healing. The smears were
fixed in methanol, stained with Giemsa and the number of
amastigotes/1000 cell nuclei was counted. The animals harbour-
ing .25–30 amastigotes/100 macrophage cell nuclei were then
treated with antileishmanial drug-Miltefosine (Zentaris, Germany)
at 40 mg/kg bodyweight daily for 5 days. The animals were
reassessed for complete cure by splenic biopsy performed on day
30 post-treatment. The animals were then autopsied as described
above and mononuclear cells were separated from inguinal and
mesenteric lymph nodes lymph nodes of cured, infected as well as
normal hamsters following the protocol of Garg et al [14] and a
suspension of 106 cells/ml was made in cRPMI. These cells were
employed for lymphoproliferative assay and in the estimation of
NO production.
Immunological assays
Assessment of Lymphocyte proliferative responses (LTT)
in cured/exposed patients and hamsters.. Lymphocytes
suspension (16106 cells/ml) of cured/exposed patients and
normal, infected (30 days p.i.) and cured hamsters was cultured
in 96-well flat bottom tissue culture plates (Nunc, Denmark). This
assay was carried out as per protocol described by [14] with some
modifications, wherein XTT (Roche diagnostics) was used instead
of 3H thymidine. About 100 ml of a predetermined concentration
(10 mg/ml) of mitogens- PHA for Patient’s PBMCs and ConA for
hamster’s lymphocytes were added to the wells in triplicate.
Similarly, PBMCs were stimulated for 5 days with recombinant
histones at a concentration of 10 mg/ml (10 mg/ml of an
individual histone protein or 2.5 mg/ml of each of the four
recombinant histones in the combination) SLD served as positive
control at a concentration of 10 mg/ml. Wells without stimulants
served as blank controls. Cultures were incubated at 37uC in a
CO2 incubator with 5% CO2 for 3 days in the case of the
mitogens, and for 5 days in the case of the antigens. Eighteen
hours prior to termination of culture, 50 ml of XTT was added to
Figure 4. Th1 and Th2 cytokine production in PBMCs from individuals of cured VL patients (6), infected individuals (6) and endemic
controls (6)., in response to rLdH2B, rLdH3, rLdH2A, rLdH4 and their combination and mix and SLD antigens, each data point represents one
individual. Values are given as concentration in pg/ml. Significance values indicate the difference between the SLD and rLdH2B, rLdH3, rLdH2A, rLdH4
and their combination and mix stimulation of PBMCs (**, p,0.01; ***, p,0.001; and ***, p,0.001).
doi:10.1371/journal.pone.0097911.g004
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100 ml of supernatants of each well and the absorbance measured
at 480 nm with 650 nm as reference wavelength.
Estimation of NO activity in macrophages of cell
lines.. Isolated lymphocytes from normal, infected (day 30
p.i.) and cured (day 30 p.t) group of hamsters were suspended in
culture medium and plated at 105 cells/well and stimulated for 3
days in case of mitogen (LPS) and 5 days in case of recombinant
antigens (either individually or in pooled form as stated above) and
SLD at 10 mg/ml. The presence of NO was assessed using Griess
reagent (Sigma, U.S.A) in the culture supernatants of macrophages
of cell lines (J774 A.1) after the exposure with the supernatant of
stimulated lymphocytes. The supernatants (100 ml), collected from
macrophage cultures 24 h after incubation, was mixed with an
equal volume of Griess reagent and left for 10 min at room
temperature. The absorbance of the reaction was measured at
540 nm in an ELISA reader [24]. The nitrite concentration in the
macrophage culture supernatant samples was extrapolated from
the standard curve plotted with sodium nitrite.
Assessment of Cytokine levels- IFN-c/IL-12/IL-10 in
lymphocytes of cured/endemic patients.. Culture of
PBMCs (16106 cells/ml) from human patients was set up in 96-
well culture plates and recombinant histone proteins viz. rLdH2B,
rLdH3, rLdH2A and rLdH4 were taken in the concentration of
10 mg/ml either individually or in pooled form (rLdH2-4) was
added in a triplicate wells. The level of IFN-c, IL-12 as well as IL-
10 was estimated by ELISA kit (OptEIA set, Pharmingen) after 5
days of incubation with antigens using supernatants. The results
were expressed as picograms of cytokine/ml, based on the
standard curves of the respective cytokine provided in the kit.
Measurement of antibody response in hamsters.. The
level of IgG antibody and its isotypes in sera samples of hamsters of
different experimental groups was measured as per protocol by
[25] with slight modifications. Briefly, 96-well ELISA plates
(corning) were coated with 0.2 mg/100 ml/well recombinant
histone proteins (individually or in pooled form) overnight at
4uC and blocked with 1.5% BSA at room temperature for 1 h.
Sera was used at a dilution of 1/100 for IgG, IgG1, and IgG2 and
kept for 2 h at RT. Biotin-conjugated mouse anti-Armenian and
Syrian hamster IgG, IgG1 and biotinylated anti-Syrian hamster
IgG2 (BD Pharmingen) were added for 1 h at room temperature
at 1/1000 dilutions and were further incubated with peroxidase-
conjugated streptavidin at 1/1000 (BD Pharmingen) for 1 h.
Finally, the substrate O-phenylenediamine dihydrochloride (Sig-
ma) was added and the plate was read at 492 nm.
Figure 5. Antibody response shown (OD value) in hamster’s serum with rLdH2B, rLdH3, rLdH2A, rLdH4 and pooled (H2-4). (a, b, c, d,
e) and in patient sample (f, g, h, i, j). Serum samples were collected from different groups of hamsters at designated time points and assayed for
specific IgG, IgG1, and IgG2 levels by ELISA. Each bar represents the pooled data (mean6S.D. value) of three replicates. Significance values indicate
the difference between the cured group and normal group (***, p,0.001).
doi:10.1371/journal.pone.0097911.g005
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Prophylactic efficacy of recombinant Histone protein(s)
with or without BCG
Four groups of hamsters containing 12–15 animals per group,
were taken for the study, wherein groups 1–3 served as controls
i.e.- group 1- unvaccinated and unchallenged (normal control);
group 2- unvaccinated and challenged (infected control) and group
3-BCG alone. The animals of group 4 were immunized
intradermally on the back with a dose of 50 mg/50 ml of either
recombinant proteins rLdH2B/rLdH3/rLdH2A/rLdH4 along
with equal volume of 0.1mg per animal BCG. Similarly, the
animals were also immunized with recombinant histone proteins
pooled (rLdH2-4+BCG) in emulsified form. Fifteen days later a
booster dose of half of the amount of recombinant histone proteins
either individually or in the pooled form along with BCG was
given intradermally to all the hamsters of Group 4 and only BCG
to the animals of group 3. Twenty one days later the hamsters of
Groups 2–4 were challenged intracardially with 107 metacyclic
promastigotes of L. donovani. Three to four animals from each
group were sacrificed as described above on days 45, 60, 90 and
120 p.c., for the assessment of parasitological and immunological
(cytokines by real-time PCR and Antibody level by ELISA and
lymphoproliferation and NO production by above mention
methods) progression of VL. The impression smears/touch blots
of different organs, namely spleen, liver, and bone marrow (femur
bone), of experimental animals were made, and the criteria for the
assessment of parasite burden was based on the counting of the
number of amastigotes per 100 cell nuclei in each organ. The
percentage of inhibition of parasite multiplication was calculated
in comparison with the unvaccinated control using the following
formula: percentage of inhibition = (number of parasite count
from infected control - number of parasites from the vaccinated
group/number of parasite count from infected control) 6100.
Animal of all the groups were given proper care and observed for
their survival period.
Quantification of mRNA cytokines and inducible NO
synthase (iNOS) in hamsters by Real time-PCR.. qRT-
PCR was performed to assess the expression of mRNAs for various
cytokines and iNOS in splenic cells. Splenic tissues were taken
from each of the three randomly chosen animals. Total RNA was
isolated using Tri-reagent (Sigma-Aldrich) and quantified by using
Gene-quant (Bio-Rad). One microgram of total RNA was used for
the synthesis of cDNA using a first-strand cDNA synthesis kit
(Fermentas). For real-time PCR, primers were designed using
Beacon Designer software (Bio-Rad) on the basis of cytokines and
iNOS mRNA sequences available on PubMed (4) (Table-2). qRT-
PCR was conducted as per the protocol described earlier [26] by
using 12.5 ml of SYBR green PCR master mix (Bio-Rad), 1 mg of
cDNA, and primers at a final concentration of 300 nM in a final
volume of 25 ml. PCR was conducted under the following
conditions: initial denaturation at 95uC for 2 min followed by 40
cycles, each consisting of denaturation at 95uC for 30 s, annealing
at 55uC for 40 s, and extension at 72uC for 40 s per cycle using the
Figure 6. Clinical outcomes following L. donovani challenge in hamsters immunized with rLdH2B+BCG, rLdH3+BCG, rLdH2A+BCG,
rLdH4+BCG and pooled (H2-4 +BCG). On day 21 after the booster, the hamsters of infected, BCG alone and vaccinated groups were challenged
intracardially with 107 metacyclic promastigotes of L. donovani. Following parameters observed Body weight (a), spleen weight (b), liver weight (c)
and Parasite burden (no. of amastigotes per 100 cell nuclei) in the spleen (d), liver (e), and bone marrow (f) on days 45, 60, 90 p.c. Data represent
mean values standard errors (SE) at the designated time points in the experiments. The hamsters immunized with rLdH2-4+BCG and challenged with
L. donovani exhibited an optimal reduction in parasite load in spleen, liver and bone marrow Significance values indicate the difference between the
vaccinated groups and infected group (***, p,0.001).
doi:10.1371/journal.pone.0097911.g006
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iQ5 multicolor real-time PCR system (Bio-Rad). cDNAs from
normal hamsters were used as ‘‘comparator samples’’ for
quantification of those corresponding to test samples whereas in
vaccination studies, cDNAs from infected hamsters were used as
‘‘comparator samples’’. All quantifications were normalized to the
housekeeping gene HPRT. A no-template control c-DNA was
included to eliminate contaminations or nonspecific reactions. The
cycle threshold (CT) value was defined as the number of PCR
cycles required for the fluorescence signal to exceed the detection
threshold value (background noise). Differences in gene expression
were calculated by the comparative CT method [25]. This method
compares test samples to a comparator sample and uses results
obtained with a uniformly expressed control gene (HPRT) to
correct for differences in the amounts of RNA present in the two
samples being compared to generate a DCT value. Results are
expressed as the degrees of difference between DCT values of test
and comparator samples.
Measurement of Antibody response in vaccinated/
immunized hamsters.. The level of IgG antibody and its
isotypes in serum samples of hamsters of different experimental
groups was measured as per protocol by [25] with slight
modifications. Briefly, 96-well ELISA plates (corning) were coated
with rLdhistones (0.2 mg/100 ml/well) overnight at 4uC and
blocked with 1.5% BSA at room temperature for 1 h. Sera was
used at a dilution of 1/100 for IgG, IgG1, and IgG2 and kept for
2 h at RT. Biotin-conjugated mouse anti-Armenian and Syrian
hamster IgG, IgG1 and biotinylated anti-Syrian hamster IgG2
(BD Pharmingen) were added for 1 h at room temperature at 1/
1000 dilutions and were further incubated with peroxidase-
conjugated streptavidin at 1/1000 (BD Pharmingen) for 1 h.
Finally, the substrate O-phenylenediamine dihydrochloride (Sig-
ma) was added and the plate was read at 492 nm.
Statistical analysis
Results were expressed as mean6S.D. Two sets of experiments
were performed and the results represent the pooled data of the
two experiments. Results were analyzed by student t test and one-
way ANOVA test followed by Dunnets or Tukeys post which ever
appropriate at each case using Prism Graphpad software program.
The upper level of significance was chosen as p,0.001 (highly
significant).
Figure 7. Cellular responses of rLdH2B, rLdH3, rLdH2A, rLdH4, and pooled (H2-4) of L.donovani in vaccinated hamsters.: (d,e,f) XTT
response of mononuclear cells (lymph nodes) from normal, L. donovani infected and treated hamsters in response to Con A, SLD and rLdH2B, rLdH3,
rLdH2A, rLdH4 and pooled (H2-4) at 10 mg/ml each. Proliferation was represented as mean OD. The data represent the means of triplicate wells6 the
S.D. Nitric oxide production (mM) by (a, b, c) J774A.1 cell line. The J774 A.1 cells were primed with the supernatants of stimulated lymphocytes (3 days
with mitogen and 5 days with antigens) of normal, infected and cured hamsters in response to rLdH2B, rLdH3, rLdH2A, rLdH4 and pooled (H2-4), SLD
and LPS respectively at 10 mg/ml each. The estimation of NO production was done using Greiss reagent in supernatants collected from macrophage
cultures 24 h after incubation and the absorbance of the reaction product was measured at 540 nm. Pooled (H2-4) shown significantly higher cellular
response and nitric oxide production. Significance values indicate the difference between the SLD and rLdH2B, rLdH3, rLdH2A, rLdH4, and pooled
(H2-4) stimulation (*, p,0.05; **, p,0.01; and ***, p,0.001).
doi:10.1371/journal.pone.0097911.g007
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Results
All the four histone proteins of L.donovani - LdH2B, LdH3,
LdH2A and LdH4 were successfully cloned, sequenced and
expressed in E. coli Rosetta strain (Fig1.a, b, c & d). H3 and H4
exhibited ,90% homology with histones of L.major and L.infantum
whereas the other two H2A and H2B were homologous to the
tune of 82-85%. It was further sub-cloned in bacterial expression
vector pET28a+ and was eluted at 250 mM imidazole concentra-
tion (Fig1.e, f, g & h). Immunoblots of lysates from L. donovani
promastigote was performed with the polyclonal antibodies raised
against each of rLdH2B, rLdH3, rLdH2A and rLdH4 respective-
ly, which detected one dominant protein band of ,17kDa,
,21kDa, ,17kDa and ,21kDa respectively (Fig1. i, j, k & l). The
presence of the lipopolysaccharides (LPS) content of the recom-
binant proteins was measured by Limulus amoebocyte lysate test
(QCL-1000, Lonza, Walkersville, MD. USA) and was found to be
below 10 endotoxin units (EU)/mg of the recombinant protein.
Recombinant histone proteins induced significant
lymphoproliferative and NO responses in normal/
infected/cured hamsters
The cellular responses of lymph node cells of cured hamsters
were assessed by XTT against the mitogen - Con A as well as
antigens- SLD, individual recombinant histone proteins – viz.
rLdH2B, rLdH3, rLdH2A and rLdH4. Simultaneously cellular
responses against the pooled combination of all the four
recombinant histone proteins -rLdH2-4 were also assessed. The
responses were compared with that of normal as well as L. donovani
infected groups that served as controls. In general, the normal and
infected controls as well as cured Leishmania infected group had
shown higher proliferative responses against ConA (Fig 2(a)). The
lymphoproliferative response against all the individual proteins
was moderately higher (1.5 to 2.5 fold) in cured hamsters as
compared to L. donovani infected hamster. However, an optimum
stimulation to the tune of 4 folds was observed when all the four
proteins were pooled (rLdH2-4) which was highly significant (P,
0.001).
NO-mediated macrophage effector mechanism is known to be
critical in the control of parasite replication in the animal model
hence its production in macrophages of cell line J774 A.1, was
studied after 24 h of incubation in the presence of individual
rLdH2B, rLdH3, rLdH2A and rLdH4 proteins as well as pooled
(rLdH2-4). For comparison, NO production in mitogenic (LPS)
stimulated and unstimulated cells served as positive as well as
negative controls respectively (Fig. 2 (b). Among the four
individual histone proteins, NO production was recorded to be
optimum against rLdH2B and rLdH2A whereas the rLdH2-4
yielded maximum NO production (p,0.001).
Figure 8. Splenic iNOS and cytokine mRNA relative fold expression profile analysis of normal and immunized hamsters on days 45
p.c. and 90 p.c by quantitative real-time RT-PCR. The expression of Th1 cytokines viz. TNF-a (c,d) as well as IFN-c (e,f) was also observed to be
,3.25 folds higher (p,0.001) in the hamsters of rLdH2-4 vaccinated group as compared to the other experimental as well as control groups. The
expression of Th2 cytokines particularly IL-10 (i,j), IL-4(k,l) and TGF-b (m,n), known to be associated with progressive VL, were significantly down-
regulated by ,3.5 (p,0.01) to ,4.5folds (p,0.001) in rLdH2-4 vaccinated hamsters and rLdH2B/rLdH3/rLdH2A/rLdH4 (,1.5folds (p,0.01)).
Significance values indicate the difference between the vaccinated group and infected group (**, p,0.01; and ***, p,0.001).
doi:10.1371/journal.pone.0097911.g008
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rLdH2-4 stimulates PBMCs from Leishmania Patients
optimally to proliferate and to express a Predominant Thl
Cytokine Profile
Further, the cellular responses (XTT and cytokine levels) of all
the four recombinant histone proteins individually as well as their
combination were validated in PBMCs of cured patients, endemic
and non-endemic controls and L.donovani-infected donors. Indi-
vidual donors in each study group were found to elicit different
responses. PBMCs of all groups exhibited higher proliferation
against PHA as compared to unstimulated control. Significantly
higher proliferative response from all the cured patients was
observed against rLdH2B, rLdH3, rLdH2A and rLdH4 as well as
their pooled (rLdH2-4) with mean OD values being 1.2 to 2.6 folds
higher than SLD (Fig.3). The results demonstrated that pooled
(rLdH2-4) was the potent immunogens recognized by a majority of
L.donovani –infected/cured/endemic individuals at different stages
or manifestations of infection.
To determine the Th1/Th2 stimulatory potential of the
rLdHistones and pooled combination (rLdH2-4) we further
assessed the cytokine levels viz. IFN-c, TNF-a, IL-12 as well as
IL-10 and IL-4 in PBMCs from cured patients as well as in
endemic contacts. The levels of IFN-c and TNF-a against pooled
(rLdH2-4) histone protein was observed to be 1.5 to 2 fold higher
as compared to individual histones in the supernatants of cured
patients (Fig.4) On the contrary, very low levels of IL-10 and IL-4
cytokines against individual rLdHistone proteins and pooled
(rLdH2-4) were detected in supernatants of cured patients followed
by endemic contacts (Fig.4). PBMCs of cured/endemic contacts
generated a mixed ThI/Th2 cytokine profile against SLD wherein
higher levels of IL-10/IL-4 and lower level of IFN-c and IL-12
Figure 9. Antibody response of Leishmania-specific IgG and its isotypes IgG1 and IgG2 in rLdH2B, rLdH3, rLdH2A, rLdH4 and pooled
(H2-4) of vaccinated hamsters in comparison to the unimmunized infected hamsters on days 45, 60, 90 p.c. Serum samples were
collected from different groups of hamsters at designated time points and assayed for specific IgG, IgG1, and IgG2 levels by ELISA. Significance values
indicate the difference between the vaccinated group and infected group (***, p,0.001).
doi:10.1371/journal.pone.0097911.g009
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were noticed in response to SLD in cured as well as endemic
contacts.
rLdH2B, rLdH3, rLdH2A and rLdH4 modulates
Leishmania-specific IgG and its isotypes in naı¨ve
hamsters as well as in cured and endemic patient sample
To assess the antibody level in the serum of cured animals, we
further estimated the level of IgG and its isotypes in response to all
the recombinant histone proteins and their pooled (rLdH2-4). In
general, we observed significantly higher (,3 to 4 fold) IgG2
response in cured animals as compared to the normal and infected
animals (Fig.5) against pooled (rLdH2-4) in comparison to the
each histone proteins. But there was no apparent difference in the
IgG1 response between the cured and the normal animals against
any of them.
Further, the level of IgG and its isotypes in cured/infected
Leishmania patients were validated. Significantly higher (,2.5 to 3
fold) IgG2 response was observed by cured patients as compared
to the endemic contacts and infected patients. However, there was
no apparent difference in the IgG1 response between the endemic
and the cured patients (Fig.5).
Immunization with recombinant LdH2-4+BCG induced
optimum prophylactic efficacy against L. donovani
challenges
The hamsters immunized with recombinant histone protein(s)
either individually or in collective forms alongwith BCG, in
general, gained considerable weight as compared to those groups
of hamsters which were immunized with BCG alone as well as to
unimmunized infected animals, when kept simultaneously upto
day 90 post challenge (p.c). The hamsters immunized with rLdH2-
4+BCG and challenged with L. donovani exhibited an optimal
reduction in parasite load (,80%) in spleen, liver and bone
marrow on day 90 p.c which was significantly higher (p,.0001)
than all the other experimental as well control groups. Lesser
efficacy (,55%) was obtained in hamsters immunized with
individual rLdH2B/rLdH3/rLdH2A/rLdH4 alongwith BCG.
The survival of rLdH2-4+BCG immunized hamsters after the
Leishmania challenge was the longest (6 months post-infection) as
compared to the unimmunized ones (day 60 to 90 p.c.) wherein
progressive increase in parasite load was observed (Fig. 6).
NO production and lymphoproliferative response were also
recorded to be significantly higher in hamsters immunized with
pooled rLdH2-4 group wherein an optimum stimulation to the
tune of 3.5 to 4.0 folds was observed in comparison to
unvaccinated infected control group of hamsters and this was
highly significant (P,0.001) (Fig 7). The cell proliferation and
nitrite production in the hamsters response was moderate against
all the individual proteins (1.2 to 1.5 fold). However, BCG
vaccinated group exhibited parasite load and immune responses
similar to infected control (Fig S1 and Fig S2).
Immunization with rLdH2-4 generates Th1-type cytokine
profile as determined by qRT-PCR
For further assessment of cellular immune response in hamsters
immunized with rLdHistones either individually or in collective
forms, the expression of Th1 and Th2 mRNA cytokines was
measured by qRT-PCR. The iNOS transcript was found to be
optimally and significantly upregulated by ,5 folds (p,0.001) in
hamsters immunized with rLdH2-4 as compared to that of
L.donovani infected group followed by those immunized with
rLdH2B/rLdH3/rLdH2A/rLdH4(,2.0folds). The expression of
Th1 cytokines viz. TNF-a as well as IFN-c was also observed to be
,3.25 folds higher (p,0.001) in the hamsters of rLdH2-4
vaccinated group as compared to the other experimental as well
as control groups. Similar was the case with IL-12 expression
which was also significantly (p,0.001) increased by ,4.0 folds in
rLdH2-4 immunized hamsters. On the other hand, the expression
of Th2 cytokines particularly IL-10, IL-4 and TGF-b, known to be
associated with progressive VL, were significantly down-regulated
by ,3.5 (p,0.01) to ,4.5folds (p,0.001) in rLdH2-4 vaccinated
hamsters and rLdH2B/rLdH3/rLdH2A/rLdH4 (,1.5folds (p,
0.01)) (Fig.8).
Immunization with rLdH2-4 generates IgG2 type
antileishmanial antibody response
The antileishmanial IgG and IgG1 were observed to be elevated
by 2 to 3 folds in the infected control group in comparison to the
group of hamsters immunized with rLdHistone and their pooled
(rLdH2-4) wherein their levels were very low. On the other hand,
there was significant elevation of IgG2 level (by 3 to 4 folds) in
group of hamsters immunized with rLdHistone either individually
or in collective forms (Fig.9). As a measure of cell mediated
immunity (CMI), the elevation of IgG2 was indicative of the
development of effective immune responses.
Discussion
Histones are structural proteins and building units of nucleo-
somes which play an important role in DNA packaging,
transcription and regulation of gene expression as well as the
organization and function of DNA within the eukaryotic nucleus.
Out of five types of histones that have been identified viz. H1 (or
H5), H2A, H2B, H3 and H4, the latter four are associated with
DNA to form nucleosomes. There are important differences
between Trypanosomatid histones and their human counterparts
[27]. First, Trypanosomatid histone genes are located on separate
chromosomes, their transcripts are polyadenylated and their
transcription is not always coordinated with DNA replication.
Second, while the globular regions of the Trypanosomatid core
histones are relatively conserved, the N-terminal domains of these
chromosomal proteins are highly divergent. Taking this informa-
tion into account, nucleosomal organization and function in
Trypanosomatids may be quite different from that seen in humans
and this knowledge could be advantageous in designing anti-
infectives against these parasites specifically. Among the trypano-
somatids the histones have been reported to be characterized in
several sp of Leishmania viz L.major and L.infantum but no reports are
there for L.donovani a causative agent of fatal anthroponotic VL.
Herein, we have carried out molecular and immunological
characterization of the histone proteins (H2B, H3, H2A, and
H4) of L. donovani.
All the four core histone genes of L.donovani were cloned and
sequenced using the primers designed on the basis of sequences of
L.major and L.infantum. Of the four, H3 and H4 exhibited ,90%
homology with histones of L.major and L.infantum whereas the other
two H2A and H2B were homologous to the tune of 82–85%.
Similarly, a comparative sequence analysis with human histones
have revealed that H2B protein of L. donovani have highly
divergent region from human histone sequence but histone H3
and H4 were more homologus to the human histone.
There are reports regarding histone proteins of L.major and
L.infantum as relevant immunogens for the host immune system
during both Leishmania infection and disease [17,18,19,28] as after
parasite destruction or spontaneous lysis, exposure to these
proteins elicits a strong host immune response. This prompted
us to assess the immunogenicity of all the four recombinant histone
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proteins either individually and in pooled histone in vitro. Since, it
has been observed that a T-cell response develops when Leishmania
infected patients are cured and they eventually become immune to
re-infection, [14,29], the ability of all the four rLdHistone proteins
to induce cellular immune response in Leishmania infected and
cured hamsters was tested and then further validation of its
immunogenicity in endemic non-immune donors (household
contacts without any clinical symptoms) and in immune patients
of VL that were cured either with amphotericin B or miltefosine,
was done. The Th1 and Th2 subsets are very clear in rodent
particularly in murine cells but not so in the human system and the
infection pattern in murine VL also do not simulate the human
profile, as it is self-limiting. On the other hand, systemic infection
of the hamster with L. donovani is akin to human VL as it results in
a relentlessly increasing visceral parasite burden, progressive
cachexia, hepato-splenomegaly, pancytopenia, hypergammaglob-
ulinemia, and, ultimately, death [26]. Hence, analysis of cellular
immune response of the individual recombinants protein rLdH2B,
rLdH3, rLdH2A and rLdH4 along with pooled (rLdH2-4) were
carried out using lymphocytes of cured hamsters as well as human
lymphocytes in order to correlate the observations made with both
hamster and humans [14,29]
During the leishmanial infections, macrophages become acti-
vated by IFN-c derived from parasite-specific T cells, and destroy
the intracellular parasites through the production of several
mediators, prime among which is NO [30,31]. In the absence of
cytokine reagents against hamsters, we studied the effect of
rLdhistone proteins on NO production. A significantly higher
cellular responses viz. lymphoproliferative as well as NO release
was observed against the pooled form of all the four recombinant
histone proteins (rLdH2-4) in all the cured hamsters as compared
to individual histone proteins. Similar observations were made in
case of endemic control and cured patients of VL wherein strong
T cell proliferation and IFN-c production was induced by the
pooled form of four histone proteins as compared to its other
counterparts. Thus, individuals who control parasite burden
successfully either following treatment in the case of patients or
due to adequate immunity, as in endemic contacts, exhibit good T
cell reactivity to the Leishmania histone proteins.
The presence of a positive immune response in all the eight
endemic contacts indicates towards the high frequency of sub-
clinical infection in an endemic area such as Bihar, India as has
been reported in other endemic parts of the world [32,33,34]. It is
well established that recovery from Leishmania infection, relies on
induction of the Th1 response [35,36] particularly the production
of IFN-c and IL-12 and improved expression of iNOS [30,37].
Some of the recombinant antigens have previously been shown to
induce lymphocyte proliferation and IFN-c production in subjects
cured of visceral and in patients with cutaneous or mucosal
leishmaniasis [16,32,38].
SLD has been observed to stimulate PBMCs from L. donovani-
infected individuals eliciting a mixed Thl- and Th2- type immune
response, but in this study, we noticed that all the recombinant
histone proteins of L. donovani particularly the pooled rLdH2-4
shifted this pattern towards an exclusive Thl (IFN-c and IL-12)
cytokine profile. These recombinant proteins stimulated PBMCs
from cured and infected patients to secrete TNF-a and stimulated
T cells from all the cured/infected patients to proliferate and
produce IFN-c associated with protective immunity. Cytokines
appear to be essential mediators of immunity to Leishmania [12]
wherein IFN-c and TNF-a synergize to induce leishmanicidal
activity in macrophages [39,40,41,42]. In our study, TNF-a and
IL-12 but not IL-10 were produced by cured/patient PBMCs
stimulated with rLdHistones. This may be due to the relatively
lower level of either TNF-a or IL-12 produced by patient PBMCs,
as well as the ability of IFN-c, produced in high amounts by
patient PBMCs, to inhibit the production of IL-10 [43]. Further, it
was observed that rLdHistone proteins down-regulated the levels
of IL-10 in patient PBMCs. The use of patient PBMCs, rather
than purified cell populations, may be more relevant to the in vivo
situation since the dominant cytokine pattern is dependent on the
interplay of modulatory cytokines. It appears that certain
Leishmania antigens may be able to elicit a dominant Thl cytokine
profile as well as inhibit the production of Th2 cytokines (IL-10) by
mechanisms that are not fully understood, because IL-12 plays a
central role in the initiation and maintenance of Thl responses in
humans and mice [44,45,46,47] and is a potent inducer of IFN-c
[31], which may inhibit the production of IL-10 [43]. IL-12 has
been shown to play a pivotal immunoregulatory role in the
development of cell-mediated immunity, including the generation
of Thl responses and IFN-c production in intracellular bacterial or
parasitic infections [24]. rLdHistones stimulated consistently
higher IL-12 production in cured and infected patient PBMCs
than those observed with SLD respectively. This may suggest a
role for IFN-c in the SLD-induced IL-12 level observed in PBMCs
of Leishmania patients, which produced higher IFN-c than normal
PBMCs after antigen stimulation.
Further, the prophylactic potential of rLdH2B, rLdH3,
rLdH2A and rLdH4 and including pooled were assessed rLdH2-
4 with the BCG adjuvant and observed that pooled rLdH2-4 with
BCG adjuvant offered greater resistance to Leishmania challenge as
an optimal reduction in parasite load (,80%) in spleen, liver and
bone marrow was observed on day 90 p.c which was significantly
higher than all the other experimental as well control groups. This
was followed by a prophylactic efficacy with individual rLdhistone
protein (,55%) in hamsters. Thus, the mixture of the four histones
was clearly additive in the prevention of VL, which corroborate
the similar findings [18,19] in which histone proteins in cocktail
form provide exclusive protection against L.major and/or L.infantum
as compared to individual form. Cocktail of DNA vaccine coding
for histone proteins (H2A, H2B, H3 and H4) was used to
immunize BALB/c mice and led to an important Th1 cellular
immune response and protection against L. major [18]. In another
study, genetic immunization of BALB/c mice with the individual
histones only resulted in a delay in lesion development, whereas
the immunization with any one of the plasmids encoding a pair of
histones provided stronger, though still partial protection against
L. major infection as compared to the combination of the four
histones. These results provide direct evidence that all the four
nucleosomal histones of Leishmania are necessary to maintain
complete protection against L.major reinfection [19]. In an another
study on BALB/c mice, histones H2A, H2B, H3 and H4 of L.
infantum elicited a specific Th1 immune response, which was
associated with an antigen-specific production of interferon (IFN-
c) and a limited humoral response to histones (dominated by the
antibodies of the IgG2a isotype) [18].
Nutshell of the study is that L.donovani histones results in a
specific Th1-like response during infection and, it is providing
exclusively protection with rLdh2-4 (cocktail). It’s promising to be
a good vaccine target.
Supporting Information
Figure S1 Clinical outcomes following L. donovani
challenge in hamsters immunized with BCG alone. On
D 21 after the booster, the hamsters of infected, BCG alone groups
were challenged intracardially with 107 metacyclic promastigotes
of L.donovani. Parameters observed - Body weight (a), spleen weight
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(b), liver weight (c) and Parasite burden (no. of amastigotes per 100
cell nuclei) in the spleen (d), liver (e) and bone marrow (f) on D45,
60 and 90 p.c. Data represent mean values with standard errors
(SE) at the designated time points in the experiments. The
hamsters immunized with BCG alone and challenged with L.
donovani exhibited similar parasite load in spleen, liver and bone
marrow as infected.
(DOC)
Figure S2 Antibody response of Leishmania-specific
IgG and its isotypes IgG1 and IgG2 in BCG vaccinated
hamsters in comparison to the unimmunized infected
hamsters on days 45, 60, 90 p.c. Serum samples were
collected from different groups of hamsters at designated time
points and assayed for specific IgG, IgG1, and IgG2 levels by
ELISA. No Significance difference was observed between the
BCG vaccinated groups and the infected group.
(DOC)
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